Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.5.1.18 (
glutathione S-transferase
)
22,582
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
cis-
Diamminedichloroplatinum
(II) (cisplatin) is an effective antitumor agent but causes dose-dependent nephrotoxicity. We examined the changes of
glutathione S-transferase
(
GST
) isoenzymes in the rat kidney after cisplatin administration. Renal
GST
-alpha activity was decreased to 33.4% of the control level and
GST
-mu activity was increased 1.9-fold after cisplatin administration. These results were confirmed by affinity chromatography of rat renal
GST
isoenzymes. Our results showed that changes of
GST
isoenzymes were associated with cisplatin-induced nephrotoxicity. We examined whether
GST
isoenzymes leaked into the urine by proximal tubular damage could provide a useful marker of cisplatin-induced nephrotoxicity. The total
GST
and
GST
-mu activities in urine correlated well with the changes of BUN, which closely parallels the course of nephrotoxicity after cisplatin administration. Our results indicated that renal
GST
-mu activity was decreased by cisplatin, and although
GST
-mu activity increased as a compensation mechanism, nephrotoxicity still appeared because of differences in substrate specificity between these two isoenzymes.
...
PMID:Role of glutathione S-transferase isoenzymes in cisplatin-induced nephrotoxicity in the rat. 829 25